As Pet Care Costs Soar, Furble Launches Canada’s First All-in-One Platform
Furble, a new Canadian-built platform to safely and legally fill pet prescriptions online, along with food and wellness products, has officially launched nationwide. With 50% of Canadian pet owners skipping vet visits due to rising costs, Furble helps close the gap by connecting pet parents to licensed community pharmacies for affordable, convenient care delivered right to their door.
The Veterinary Industry Isn’t Recession-Proof After All, and the Data Is Alarming
For years, the veterinary field has comforted itself with the same familiar mantra: “We’re recession-proof. People will always spend money on their pets.” But a massive new analysis is challenging that belief—and the results are startling enough that every clinic owner, manager, and industry leader should be paying attention.
Veterinary Practices Brace for Recession: Are You Ready for the Coming Downturn?
Veterinary medicine in the United States may have long been considered “recession-resistant,” but new research suggests that the industry is far from immune to economic cycles. In a study titled Anticipating the Downturn: Business Cycle Forecasting for Veterinary Practice Strategy in the United States, researchers used advanced time-series econometrics to analyze veterinary-specific inflation and expenditure patterns, revealing a distinct business cycle for veterinary services that often lags behind the broader economy by years.
The Cost of Becoming a Surgeon: What Vets Need to Know About How Our Training Compares to Human Medicine in the UK
For anyone considering a career in surgery, the path is long, demanding, and expensive, but the journey differs dramatically depending on whether you are holding a scalpel for humans or for animals. Medicine and veterinary science share a rigorous undergraduate foundation, yet their postgraduate worlds diverge in structure, funding, and financial risk.
Biovenic's Tech Goes Veterinary
For the past two decades, CAR therapies have revolutionized human oncology. Meanwhile, similar strategies in veterinary medicine have taken hold. Biovenic is changing that narrative by providing tailored solutions—veterinary CAR-T therapydevelopment—to tackle challenges in developing immune cell therapies for veterinary use.
Zoetis announced the launch of Vanguard Recombishield
Zoetis announced the U.S. launch of Vanguard® Recombishield™ (Bordetella bronchiseptica vaccine), a new injectable vaccine to protect against Bordetella bronchiseptica, also known as kennel cough. Licensed by the U.S. Department of Agriculture (USDA) on March 4, 2025, Recombishield is the first and only vaccine for dogs with pertactin protein for an optimized immune response. This innovation in Bordetella protection uses recombinant technology to provide a comfortable immunization experience for the pet, with minimal pain, swelling, stinging and sensitivity.